Latin American and Caribbean advocacy fellowship programme on drug policy reform

News

Latin American and Caribbean advocacy fellowship programme on drug policy reform

23 April 2015

DEADLINE OF SUBMISSIONS: May 29, 2015

About the fellowship

The Global Drug Policy and Latin America and Caribbean Programs at Open Society Foundations are proud to invite applications to the 2015 Latin American Advocacy Fellowship Program on Drug Policy Reform. Fellows will be hosted in drug policy organizations in London (Release) or Amsterdam (Transnational Institute). This program supports those working in sectors related to drug policy in order to improve their advocacy skills and to enhance their capacity in working with the media on drug policy. The fellowship seeks to add to a core group of existing high- profile drug policy activists in the Latin American and Caribbean regions, including people not necessarily working full-time on drug-related issues.

Fellowship objectives

The objectives of the fellowship are for the participants to:

  • increase their knowledge of global drug policy reform issues with a focus on Latin America and the Caribbean;
  • increase their understanding of the international drug control system and conflicts with other United Nations priorities;
  • have a greater awareness of the drug policy reform landscape and key figures within that movement;
  • establish links with those working in drug policy;
  • build and develop their communications skills, including for media interviews, press releases, press databases, public speaking;
  • have an understanding of the tools for debate, so that they can confidently challenge anti-reform positions;
  • improve their confidence as drug policy advocates both through participation in the program and through ongoing support from the host organization.

Fellows will attend a two-week program with one of the two drug policy organizations: Release in London, UK or Transnational Institute (TNI) in Amsterdam, Netherlands.

Click here for more information.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.